$PCRX
Pacira Biosciences Inc

2022 Q4 Form 10-Q Financial Statement

#000139681422000068 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $172.0M $167.5M
YoY Change 8.02% 31.12%
Cost Of Revenue $61.92M $50.68M
YoY Change 58.73% 46.25%
Gross Profit $110.0M $116.8M
YoY Change -8.44% 25.48%
Gross Profit Margin 63.99% 69.74%
Selling, General & Admin $63.97M $61.28M
YoY Change 24.93% 25.56%
% of Gross Profit 58.13% 52.47%
Research & Development $17.51M $19.41M
YoY Change 12.83% 67.6%
% of Gross Profit 15.91% 16.62%
Depreciation & Amortization $30.41M $5.800M
YoY Change 132.64% 52.63%
% of Gross Profit 27.63% 4.97%
Operating Expenses $95.80M $80.69M
YoY Change 28.81% 33.62%
Operating Profit $14.24M $21.29M
YoY Change -68.92% -32.27%
Interest Expense -$8.256M $9.856M
YoY Change -20.18% 34.41%
% of Operating Profit -57.97% 46.3%
Other Income/Expense, Net $81.00K -$19.22M
YoY Change -222.73% 166.87%
Pretax Income -$18.07M $2.069M
YoY Change 191.51% -91.46%
Income Tax -$7.966M $2.762M
% Of Pretax Income 133.49%
Net Earnings -$10.10M -$693.0K
YoY Change 96.92% -103.92%
Net Earnings / Revenue -5.87% -0.41%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.22 -$0.02
COMMON SHARES
Basic Shares Outstanding 45.88M shares 45.82M shares
Diluted Shares Outstanding 45.83M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $288.7M $328.7M
YoY Change -56.03% -52.62%
Cash & Equivalents $104.1M $109.4M
Short-Term Investments $184.5M $219.3M
Other Short-Term Assets $15.22M $14.42M
YoY Change 3.06% 27.46%
Inventory $96.06M $96.80M
Prepaid Expenses
Receivables $98.40M $93.47M
Other Receivables $0.00 $0.00
Total Short-Term Assets $498.3M $533.4M
YoY Change -42.46% -35.14%
LONG-TERM ASSETS
Property, Plant & Equipment $183.5M $193.6M
YoY Change -2.59% 21.61%
Goodwill $163.2M $157.4M
YoY Change 12.43% 58.19%
Intangibles $540.5M $581.0M
YoY Change -13.37% 541.13%
Long-Term Investments $64.38M $43.75M
YoY Change 192.8% 106.46%
Other Assets $160.3M $155.5M
YoY Change 4.53% 66.76%
Total Long-Term Assets $1.183B $1.201B
YoY Change -2.19% 125.05%
TOTAL ASSETS
Total Short-Term Assets $498.3M $533.4M
Total Long-Term Assets $1.183B $1.201B
Total Assets $1.681B $1.734B
YoY Change -18.99% 27.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.22M $12.93M
YoY Change 44.36% 63.81%
Accrued Expenses $89.79M $76.36M
YoY Change -29.61% 50.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $33.65M $33.87M
YoY Change -91.02% -78.25%
Total Short-Term Liabilities $147.8M $131.5M
YoY Change -71.64% -41.75%
LONG-TERM LIABILITIES
Long-Term Debt $655.8M $714.0M
YoY Change -2.77% 118.92%
Other Long-Term Liabilities $9.669M $19.11M
YoY Change -51.59% 153.04%
Total Long-Term Liabilities $9.669M $19.11M
YoY Change -51.59% 153.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $147.8M $131.5M
Total Long-Term Liabilities $9.669M $19.11M
Total Liabilities $906.2M $964.2M
YoY Change -32.62% 51.28%
SHAREHOLDERS EQUITY
Retained Earnings -$148.8M -$138.6M
YoY Change -29.8% -32.94%
Common Stock $46.00K $46.00K
YoY Change 2.22% 2.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $775.0M $770.1M
YoY Change
Total Liabilities & Shareholders Equity $1.681B $1.734B
YoY Change -18.99% 27.9%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$10.10M -$693.0K
YoY Change 96.92% -103.92%
Depreciation, Depletion And Amortization $30.41M $5.800M
YoY Change 132.64% 52.63%
Cash From Operating Activities $42.04M $42.65M
YoY Change 81.08% -29.25%
INVESTING ACTIVITIES
Capital Expenditures $5.492M -$5.181M
YoY Change -159.92% -60.38%
Acquisitions
YoY Change
Other Investing Activities $16.68M -$42.33M
YoY Change -78.08% 92.42%
Cash From Investing Activities $11.19M -$47.52M
YoY Change -83.28% 35.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -58.51M -7.775M
YoY Change -116.19% -354.75%
NET CHANGE
Cash From Operating Activities 42.04M 42.65M
Cash From Investing Activities 11.19M -47.52M
Cash From Financing Activities -58.51M -7.775M
Net Change In Cash -5.285M -12.64M
YoY Change -101.17% -144.71%
FREE CASH FLOW
Cash From Operating Activities $42.04M $42.65M
Capital Expenditures $5.492M -$5.181M
Free Cash Flow $36.55M $47.84M
YoY Change 12.86% -34.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001396814
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006RetrospectiveMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35060
dei Entity Registrant Name
EntityRegistrantName
PACIRA BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0619477
dei Entity Address Address Line1
EntityAddressAddressLine1
5401 West Kennedy Boulevard, Suite 890
dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33609
dei City Area Code
CityAreaCode
813
dei Local Phone Number
LocalPhoneNumber
553-6680
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PCRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45882088 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109424000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
585578000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
219301000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
70831000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93471000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96318000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
96799000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
98550000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14416000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14771000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
533411000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
866048000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
17394000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193646000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
188401000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
69662000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
76410000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
157361000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
145175000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
581002000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
623968000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
155531000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
153364000 usd
CY2022Q3 pcrx Equity Method Investments And Other Assets
EquityMethodInvestmentsAndOtherAssets
26358000 usd
CY2021Q4 pcrx Equity Method Investments And Other Assets
EquityMethodInvestmentsAndOtherAssets
21987000 usd
CY2022Q3 us-gaap Assets
Assets
1734365000 usd
CY2021Q4 us-gaap Assets
Assets
2075353000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
12933000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10543000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76357000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
127555000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8364000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7891000 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
350466000 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
350466000 usd
CY2022Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
33872000 usd
CY2021Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
24234000 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
429000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
131526000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
521118000 usd
CY2022Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
404151000 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
339267000 usd
CY2022Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
309848000 usd
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
335263000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
65401000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71727000 usd
CY2022Q3 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
34204000 usd
CY2021Q4 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
57598000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19112000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19972000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
964242000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1344945000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45864319 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45864319 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44734308 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44734308 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
45000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
909396000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
942091000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-138649000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-211895000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-670000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
167000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
770123000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
730408000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1734365000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2075353000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
167466000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127722000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
494868000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
382339000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
50678000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
34651000 usd
us-gaap Cost Of Revenue
CostOfRevenue
137379000 usd
us-gaap Cost Of Revenue
CostOfRevenue
101248000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19405000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11578000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67292000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40031000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61283000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47856000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
190546000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
147191000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14322000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1967000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42966000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5900000 usd
CY2022Q3 pcrx Acquisition Related Gain Loss Product Discontinuation Costs And Other Net
AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
-489000 usd
CY2021Q3 pcrx Acquisition Related Gain Loss Product Discontinuation Costs And Other Net
AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
-237000 usd
pcrx Acquisition Related Gain Loss Product Discontinuation Costs And Other Net
AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
13232000 usd
pcrx Acquisition Related Gain Loss Product Discontinuation Costs And Other Net
AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
-2256000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
146177000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
96289000 usd
us-gaap Costs And Expenses
CostsAndExpenses
424951000 usd
us-gaap Costs And Expenses
CostsAndExpenses
296626000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
21289000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
31433000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
69917000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
85713000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1234000 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
177000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1757000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
816000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
9856000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
7333000 usd
us-gaap Interest Expense
InterestExpense
28935000 usd
us-gaap Interest Expense
InterestExpense
21327000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10598000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11369000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2600000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19220000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7202000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38547000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23111000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2069000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24231000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31370000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62602000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2762000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6571000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5359000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15492000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17660000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
us-gaap Net Income Loss
NetIncomeLoss
47110000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45831000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44476000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44151000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45831000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45463000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52220000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45674000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17660000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
us-gaap Net Income Loss
NetIncomeLoss
47110000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-163000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-30000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1056000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-168000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
98000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
219000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-65000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-28000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-837000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-165000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-758000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17632000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25174000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46945000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
756636000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1563000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12682000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-65000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
770123000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
687168000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3018000 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10784000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-28000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17660000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
718602000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
730408000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23498000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1821000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35415000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3040000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-837000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
770123000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
619688000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19039000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1574000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31356000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-165000 usd
us-gaap Net Income Loss
NetIncomeLoss
47110000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
718602000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
us-gaap Net Income Loss
NetIncomeLoss
47110000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2895000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12953000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
61095000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15478000 usd
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
2957000 usd
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
1976000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2107000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17245000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-193000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
10000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35415000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
31356000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-23394000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2147000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
10000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
184000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2641000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2847000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3070000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1751000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2560000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
568000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-907000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4681000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-825000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-23560000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17034000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-623000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
1996000 usd
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
5662000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103237000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
102502000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24584000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36700000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
319426000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
513492000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
152636000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
470614000 usd
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
32000000 usd
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
0 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
13000000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
17187000 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
9057000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-236374000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87708000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23482000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19049000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1820000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1574000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
18750000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1338000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-343017000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19285000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-476154000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34079000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
585578000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99957000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109424000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134036000 usd
us-gaap Interest Paid Net
InterestPaidNet
23620000 usd
us-gaap Interest Paid Net
InterestPaidNet
5096000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4216000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2259000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3040000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5486000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4719000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
400000 usd
CY2022Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period3
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3
7900000 usd
pcrx Business Combination Provisional Information Initial Accounting Incomplete Adjustment Deferred Tax Assets
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets
-10970000 usd
pcrx Business Combination Provisional Information Initial Accounting Incomplete Adjustment Assets
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets
-10970000 usd
pcrx Business Combination Provisional Information Initial Accounting Incomplete Adjustment Accrued Expenses
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses
1216000 usd
pcrx Business Combination Provisional Information Initial Accounting Incomplete Adjustment Liabilities
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities
1216000 usd
pcrx Business Combination Provisional Information Initial Accounting Incomplete Adjustment Net Assets
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets
-12186000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
12186000 usd
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
0 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
8762000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
35602000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
36337000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
35026000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
35182000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
26171000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27031000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
96799000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
98550000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
295174000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
273641000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101528000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85240000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193646000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
188401000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
5800000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
3800000 usd
us-gaap Depreciation
Depreciation
18000000 usd
us-gaap Depreciation
Depreciation
9600000 usd
CY2022Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
3100000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2400000 usd
CY2022Q3 pcrx Number Of Leases
NumberOfLeases
2 lease
CY2021Q4 us-gaap Goodwill
Goodwill
145200000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3440000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2919000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10509000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
540000 usd
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
416000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1520000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1318000 usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
169000 usd
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
169000 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
3811000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
3335000 usd
us-gaap Lease Cost
LeaseCost
11860000 usd
us-gaap Lease Cost
LeaseCost
10080000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9922000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9868000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
212000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M9D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y5M15D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0695
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0688
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3261000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13304000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13435000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12575000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12310000 usd
CY2022Q3 pcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
39423000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
94308000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
20543000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
73765000 usd
pcrx Lessee Operating Lease Lease Not Yet Commenced Number Of Contracts
LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
1 segment
CY2022Q3 pcrx Lessee Operating Lease Lease Not Yet Commenced Liability Remainder Of Fiscal Year
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear
81000 usd
CY2022Q3 pcrx Lessee Operating Lease Lease Not Yet Commenced Liability Due Year One
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne
492000 usd
CY2022Q3 pcrx Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Two
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo
493000 usd
CY2022Q3 pcrx Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Three
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree
503000 usd
CY2022Q3 pcrx Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Four
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour
505000 usd
CY2022Q3 pcrx Lessee Operating Lease Lease Not Yet Commenced Liability Due After Year Four
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour
443000 usd
CY2022Q3 pcrx Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
2517000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
157400000 usd
CY2022Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period1
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
57300000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
70088000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
520002000 usd
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
651090000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
70088000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
581002000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27122000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
562968000 usd
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
651090000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27122000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
623968000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43000000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5900000 usd
CY2022Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period2
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
37400000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
14300000 usd
CY2022Q3 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period4
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4
2200000 usd
pcrx Settlement Period Convertible Debt Conversion Request
SettlementPeriodConvertibleDebtConversionRequest
P40D
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
9343000 usd
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1704000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
26724000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
5122000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
903000 usd
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
666000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2956000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1976000 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
695000 usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5844000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2107000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17245000 usd
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1085000 usd
CY2021Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
881000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2852000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3016000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
9856000 usd
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
7333000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
28935000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
21327000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0542
CY2021Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0670
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0566
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0670
CY2022Q3 us-gaap Share Price
SharePrice
53.19
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
12802000 usd
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
17187000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-11642000 usd
CY2021 pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Gain Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
-88000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
18259000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
13000000 usd
pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
-10000000 usd
pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Gain Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
-158000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
21101000 usd
pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
-10000000 usd
CY2022Q3 pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
-10000000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
238010000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1315000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
236695000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
70651000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
182000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
70831000 usd
CY2022Q3 us-gaap Interest Receivable
InterestReceivable
400000 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
100000 usd
pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2021 pcrx Number Of Major Customers
NumberOfMajorCustomers
4 segment
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
300000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
100000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12682000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10784000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35415000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31356000 usd
CY2022Q3 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
6711000 usd
CY2021Q3 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
6458000 usd
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
20038000 usd
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
19507000 usd
CY2022Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
5758000 usd
CY2021Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
4126000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
14588000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
11164000 usd
CY2022Q3 pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
213000 usd
CY2021Q3 pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
200000 usd
pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
789000 usd
pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
685000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12682000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
10784000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35415000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
31356000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6050540 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1034230 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
60.16
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
667940 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
35.18
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
88766 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
54.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
24447 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
78.76
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6303617 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
52.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.66
CY2022Q2 pcrx Employee Stock Purchase Plans Shares Amount Authorized To Be Sold During Period Increase
EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease
500000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
36729 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-693000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17660000 usd
us-gaap Net Income Loss
NetIncomeLoss
26011000 usd
us-gaap Net Income Loss
NetIncomeLoss
47110000 usd
CY2022Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2021Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
3112000 usd
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-693000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
17660000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
29123000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
47110000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45831000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44476000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44151000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
51000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45831000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45463000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52220000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45674000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13132000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3102000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3513000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2036000 shares
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6571000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9230000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
25167000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
39610000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
66962000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-7161000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-936000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-8240000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4360000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2069000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24231000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31370000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62602000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2762000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5359000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15492000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.33
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.17
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
CY2022Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
194000 usd
CY2021Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
445000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
4259000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
445000 usd
CY2022Q3 pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
1532000 usd
CY2021Q3 pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
1396000 usd
pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
10162000 usd
pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
1403000 usd
CY2022Q3 pcrx Acquisition Related Charges Product Discontinuation And Other
AcquisitionRelatedChargesProductDiscontinuationAndOther
489000 usd
CY2021Q3 pcrx Acquisition Related Charges Product Discontinuation And Other
AcquisitionRelatedChargesProductDiscontinuationAndOther
237000 usd
pcrx Acquisition Related Charges Product Discontinuation And Other
AcquisitionRelatedChargesProductDiscontinuationAndOther
-13232000 usd
pcrx Acquisition Related Charges Product Discontinuation And Other
AcquisitionRelatedChargesProductDiscontinuationAndOther
2256000 usd

Files In Submission

Name View Source Status
R40.htm Edgar Link pending
0001396814-22-000068-index-headers.html Edgar Link pending
0001396814-22-000068-index.html Edgar Link pending
0001396814-22-000068.txt Edgar Link pending
0001396814-22-000068-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcrx-20220930.htm Edgar Link pending
pcrx-20220930.xsd Edgar Link pending
pcrx-20220930_g1.jpg Edgar Link pending
pcrx-20220930_g2.jpg Edgar Link pending
pcrx-9302022xex311.htm Edgar Link pending
pcrx-9302022xex312.htm Edgar Link pending
pcrx-9302022xex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
pcrx-20220930_def.xml Edgar Link unprocessable
pcrx-20220930_cal.xml Edgar Link unprocessable
pcrx-20220930_pre.xml Edgar Link unprocessable
pcrx-20220930_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pcrx-20220930_lab.xml Edgar Link unprocessable